HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Translational and Clinical Cancer Research

  • Liquid Biopsies and Biomarker Discovery
  • Role of Artificial Intelligence in Cancer Diagnostics
  • Innovative Clinical Trial Designs in Oncology
  • Real-World Data and Evidence in Cancer Treatment

Translational and clinical cancer research bridges the gap between laboratory discoveries and patient care, advancing our understanding of cancer and its treatment. This dynamic field focuses on converting basic scientific findings into effective therapies, diagnostics, and preventive measures. Researchers collaborate across disciplines to explore the genetic, molecular, and environmental factors driving cancer progression. Clinical trials play a pivotal role, offering innovative treatments that improve survival rates and quality of life. By integrating patient data with cutting-edge technologies such as precision medicine, immunotherapy, and genomic profiling, translational research enables personalized approaches tailored to individual needs. The ultimate goal is to accelerate the development of breakthroughs, ensuring that scientific advancements rapidly benefit patients and reshape the future of cancer care.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp